BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12734193)

  • 41. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
    Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
    J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2.
    Wang S; Skorczewski J; Feng X; Mei L; Murphy-Ullrich JE
    J Biol Chem; 2004 Aug; 279(33):34311-22. PubMed ID: 15184388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells.
    Kim BC; van Gelder H; Kim TA; Lee HJ; Baik KG; Chun HH; Lee DA; Choi KS; Kim SJ
    J Biol Chem; 2004 Jul; 279(27):28458-65. PubMed ID: 15107418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells.
    Simeone DM; Zhang L; Graziano K; Nicke B; Pham T; Schaefer C; Logsdon CD
    Am J Physiol Cell Physiol; 2001 Jul; 281(1):C311-9. PubMed ID: 11401854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B.
    Xu F; Xu Z; Zhang R; Wu Z; Lim JH; Koga T; Li JD; Shen H
    Respir Res; 2008 Jan; 9(1):16. PubMed ID: 18237405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha.
    Watanabe T; Jono H; Han J; Lim DJ; Li JD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3563-8. PubMed ID: 14993593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
    Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
    J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.
    Fu Y; O'Connor LM; Shepherd TG; Nachtigal MW
    Biochem Biophys Res Commun; 2003 Oct; 310(2):391-7. PubMed ID: 14521923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
    Yue J; Mulder KM
    J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19.
    Kimoto K; Nakatsuka K; Matsuo N; Yoshioka H
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2431-7. PubMed ID: 15223827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
    Kakonen SM; Selander KS; Chirgwin JM; Yin JJ; Burns S; Rankin WA; Grubbs BG; Dallas M; Cui Y; Guise TA
    J Biol Chem; 2002 Jul; 277(27):24571-8. PubMed ID: 11964407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2.
    Selvamurugan N; Kwok S; Alliston T; Reiss M; Partridge NC
    J Biol Chem; 2004 Apr; 279(18):19327-34. PubMed ID: 14982932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of MAP kinase cascades in Smad7 transcriptional regulation.
    Uchida K; Suzuki H; Ohashi T; Nitta K; Yumura W; Nihei H
    Biochem Biophys Res Commun; 2001 Nov; 289(2):376-81. PubMed ID: 11716483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.
    Wang L; Ma R; Flavell RA; Choi ME
    J Biol Chem; 2002 Dec; 277(49):47257-62. PubMed ID: 12374793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
    Franklin CC; Kraft AS
    J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses.
    Yu L; Hébert MC; Zhang YE
    EMBO J; 2002 Jul; 21(14):3749-59. PubMed ID: 12110587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.
    Lo RK; Cheung H; Wong YH
    J Biol Chem; 2003 Dec; 278(52):52154-65. PubMed ID: 14551213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
    Ohshima T; Shimotohno K
    J Biol Chem; 2003 Dec; 278(51):50833-42. PubMed ID: 14514699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis.
    Hata K; Nishimura R; Ikeda F; Yamashita K; Matsubara T; Nokubi T; Yoneda T
    Mol Biol Cell; 2003 Feb; 14(2):545-55. PubMed ID: 12589053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.